GLYMAB THERAPEUTICS LIMITED

16538942
Active Oxford

Research and experimental development on biotechnology

Research and experimental development on biotechnology
G

GLYMAB THERAPEUTICS LIMITED

16538942

Research and experimental development on biotechnology

Founded 24 Jun 2025 Active Oxford, United Kingdom website.com
Research and experimental development on biotechnology
Accounts Due 24 Mar 2027 8 months remaining
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Bellhouse Building Sanders Road Oxford Science Park Oxford OX4 4GD United Kingdom

Full company profile for GLYMAB THERAPEUTICS LIMITED (16538942), an active company based in Oxford, United Kingdom. Incorporated 24 Jun 2025. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Awaiting first accounts
For period ending 30 June 2026
Due by 24 March 2027 8 months remaining

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
L'huillier, Phillip JohnDirectorNew ZealanderEngland6424 Jun 2025Active

Shareholders

Shareholders (1)

Scancell Holdings Plc
100.0%
1

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Scancell Holdings Plc

United Kingdom

Active
Notified 24 Jun 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

SCANCELL HOLDINGS PLC united kingdom
GLYMAB THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Apr 2026OfficersTermination of Sathijeevan Nirmalananthan as director on 24 Apr 2026
26 Apr 2026OfficersAppointment of Alexander Hayward as director on 24 Apr 2026
26 Apr 2026OfficersTermination of Sathijeevan Nirmalananthan as director on 24 Apr 2026
25 Jun 2025OfficersAppointment of Professor Linda Gillian Durrant as director on 25 Jun 2025
24 Jun 2025IncorporationCompany incorporated
26 Apr 2026 Officers

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

26 Apr 2026 Officers

Appointment of Alexander Hayward as director on 24 Apr 2026

26 Apr 2026 Officers

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

25 Jun 2025 Officers

Appointment of Professor Linda Gillian Durrant as director on 25 Jun 2025

24 Jun 2025 Incorporation

Company incorporated

Recent Activity

Latest Activity

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

2 months ago on 26 Apr 2026

Appointment of Alexander Hayward as director on 24 Apr 2026

2 months ago on 26 Apr 2026

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

2 months ago on 26 Apr 2026

Appointment of Professor Linda Gillian Durrant as director on 25 Jun 2025

1 years ago on 25 Jun 2025

Company incorporated

1 years ago on 24 Jun 2025